U.S. signs agreement with AstraZeneca to develop, supply COVID-19 antibody treatment

The U.S. health agency will provide the funding to AstraZeneca for two Phase 3 clinical trials under operation Warp Speed, which is aimed at speeding up treatments and vaccines for COVID-19.AstraZeneca said it plans to supply up to 100,000 doses starting towards the end of 2020 and the US Government can acquire up to an additional one million doses in 2021 under a separate agreement.In a video posted on Twitter on Wednesday, Trump credited Regeneron Pharmaceuticals Inc'stherapeutic for his recov